Tablet-based weight loss treatments Contain a GLP-1 receptor agonist (the same active ingredient as Wegovy) Taken once daily, rather than once weekly by injection Clinically tested with results comparable to injectable options A non-injectable alternative for those who prefer not to use a pen Easier to fit into everyday life for some people No refrigeration or injection equipment required The same clinically-led approach, in a simpler format Two large clinical trials give us the best picture so far
Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients
9 Dozens of animal studies have demonstrated this effect through reduced dependence on and addiction to alcohol
The Science of Success: Why Precision Matters Weight loss is often framed as a matter of willpower, but the science behind tirzepatide proves it is a matter of biology
Infants in day care centers have been found to have a higher risk of contracting bacteria that can cause intestinal infections that lead to diarrhea
By enhancing insulin function, reducing inflammation, and stabilizing glucose levels, GLP-1 antagonists may support long-term weight management and lower the risk of metabolic diseases like Type 2 diabetes and heart disease